India to Philippines: Tobramycin Export Trade Route

The India to Philippines Tobramycin corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $262.3K USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's tobramycin manufacturing sector.

Across 17 active suppliers, the average shipment value stands at $5.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with tobramycin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #14 among India's top tobramycin export destinations globally.

On the import side, key buyers of Indian tobramycin in Philippines include BRADY PHARMA INC, AFREE PHARMACEUTICAL DISTRIBUTION, AIRLIFE INTERNATIONAL TRADING CORP and 17 others. BRADY PHARMA INC is the single largest importer with 6 shipments valued at $41.3K USD.

India's tobramycin exports to Philippines are driven primarily by a handful of large-scale manufacturers. SCOTT EDIL PHARMACIA LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED, ALWIN DMD PHARMACEUTICALS, MAKCUR LABORATORIES LIMITED — together account for 53% of total trade value on this route. The average shipment value of $5.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines finished formulation tobramycin ophthalmic solution usp 0.3% batch xo3l008 mfg date.nos and tob-dex [tobramycin 0.3%w/v + dexamethsone w/v 0.1% 5ml], suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BRADY PHARMA INC is the largest importer with 6 shipments worth $41.3K USD — representing 16% of all tobramycin imports from India on this route. A total of 20 buyers are active on this corridor.